NCT05306587View on ClinicalTrials.gov

Daratumumab Provided at Home Experience An Open, Single-center, Mixed-method Project.

CompletedOBSERVATIONAL
Enrollment

40

Participants

Timeline

Start Date

April 1, 2022

Primary Completion Date

December 15, 2023

Study Completion Date

January 1, 2024

Conditions
Multiple Myeloma
Interventions
DRUG

Darzalex

Investigate the home administration of Darzalex SC reported by both patients and healthcare professionals compared to the hospital administration setting.

Trial Locations (1)

5000

Odense University Hospital, Odense

All Listed Sponsors
lead

Thomas Lund

OTHER